Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
Infectious pancreatic necrosis virus (IPNV), the etiologic agent of infectious pancreatic necrosis in salmonid fish, causes significant losses to the aquaculture industry. The gene for the viral capsid protein (VP2) was cloned into a yeast expression vector and expressed in Saccharomyces cerevisae . Expression of the capsid gene in yeast resulted in formation of approximately 20 nanometer sub-viral particles composed solely of VP2 protein. Anti-IPNV antibodies were detected in rainbow trout vaccinated either by injection of purified VP2-subviral particles (rVP2-SVP) or by feeding recombinant yeast expressing rVP2-SVP. Challenge of rVP2-SVP immunized trout with a heterologous IPNV strain and subsequent viral load determination showed that both injection and orally vaccinated fish had lower IPNV loads than naive or sham-vaccinated fish. This study demonstrates the ability of rVP2-SVPs to induce a specific immune response and the ability of immunized fish to reduce the viral load after an experimentally induced IPNV infection. The invention is not limited to IPNV, and is applicable to other similar viruses for which SVPs can be made and administered to fish.
1. A composition comprising aquatic species feed and a crude yeast lysate, wherein the crude yeast lysate comprises a recombinant yeast expressing Infectious Necrosis Virus segment A protein consisting of capsid protein 2 (VP2) as recombinant VP2 sub-viral particles (rVP2-SVPs), wherein the rVP2-SVPs are not purified from the yeast and wherein the rVP2-SVPs are about 20 nanometers in diameter size.
2. The composition according to claim 1 , wherein the aquatic species feed is fish food for oral administration to fish for controlling Infectious Pancreatic Necrosis Virus (IPNV) therein.
3. The composition according to claim 1 , wherein the yeast does not generate pyrogens that must be removed before administration to an aquatic species.
4. An oral vaccine for controlling Infectious Pancreatic Necrosis Virus (IPNV), wherein the oral vaccine comprises the recombinant yeast according to claim 1 .
5. The oral vaccine according to claim 4 , wherein the recombinant yeast was mixed with aquatic feed for feeding to an aquatic species.
6. A method to enhance immunity against IPNV comprising:
administering an effective amount of the composition according to claim 1 to aquatic species for a period of at least seven days.
7. A method of generating a composition comprising aquatic species feed and a crude yeast lysate comprising the steps of:
(a) providing a recombinant yeast expression vector comprising a polynucleotide encoding IPNV Segment A proteins consisting of capsid protein 2, VP2;
(b) transfecting yeast with the recombinant yeast expression vector; and
(c) maintaining suitable conditions for expression of rVP2-sub-viral particles (SVPs) of Infectious Pancreatic Necrosis Virus (IPNV);
(d) harvesting the yeast that expressed rVP2-SVPs; and
(e) combining the yeast that expressed rVP2-SVPs with the aquatic species feed, wherein the rVP2-SVPs are not purified or isolated from the yeast and wherein the rVP2-SVPs are about 20 nanometers in diameter size.
8. The method according to claim 7 , wherein the aquatic species feed is fish food for oral administration to fish for controlling IPNV therein.